Literature DB >> 7242613

Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications.

J L Wautier, R C Paton, M P Wautier, D Pintigny, E Abadie, P Passa, J P Caen.   

Abstract

We studied the adhesion of erythrocytes from 30 diabetic patients and 25 controls to human endothelial cells. Washed erythrocytes were labeled with 51Cr and added to confluent endothelial cells cultured from umbilical veins. After incubation at 37 degrees C, the nonadherent erythrocytes were removed by sequential washings. The percentage of erythrocytes adhering to cultured endothelium after each wash was significantly higher when erythrocytes were from diabetics than when they were from controls (P less than 0.005). After the fifth wash, the mean adhesion ratio (percentage of adhering diabetic red cells: percentage of adhering control red cells) was 2.33 (range, 0.8 to 5.2). Increased adhesion was related to the extent of vascular complications in the diabetics, as assessed by a vascular score. With the same technique, fewer erythrocytes adhered to plastic and to cultured human fibroblasts than to endothelial cells, although the adhesion of the diabetic red cells to these surfaces was higher than that of the controls. These results suggest that in diabetes there is an intrinsic erythrocyte abnormality that is related to vascular disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7242613     DOI: 10.1056/NEJM198107303050501

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  36 in total

1.  Vitamin E and the susceptibility of erythrocytes and reconstituted liposomes to oxidative stress in aged diabetics.

Authors:  S Urano; M Hoshi-Hashizume; N Tochigi; M Matsuo; M Shiraki; H Ito
Journal:  Lipids       Date:  1991-01       Impact factor: 1.880

Review 2.  Endothelial cells in culture: an experimental model for the study of vascular dysfunctions.

Authors:  O Chappey; M P Wautier; B Boval; J L Wautier
Journal:  Cell Biol Toxicol       Date:  1996-12       Impact factor: 6.691

3.  The effect of pentoxifylline on filterability of normal red blood cells and their adhesiveness to cultured endothelial cells.

Authors:  S O Sowemimo-Coker; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Stroke topography and outcome in relation to hyperglycaemia and diabetes.

Authors:  L Kiers; S M Davis; R Larkins; J Hopper; B Tress; S C Rossiter; J Carlin; S Ratnaike
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

5.  A two phase field model for tracking vesicle-vesicle adhesion.

Authors:  Rui Gu; Xiaoqiang Wang; Max Gunzburger
Journal:  J Math Biol       Date:  2016-03-24       Impact factor: 2.259

6.  Oleate, not ligands of the receptor for advanced glycation end-products, promotes proliferation of human arterial smooth muscle cells.

Authors:  C B Renard; B Askari; L A Suzuki; F Kramer; K E Bornfeldt
Journal:  Diabetologia       Date:  2003-11-01       Impact factor: 10.122

Review 7.  Vascular factors in diabetic neuropathy.

Authors:  S Tesfaye; R Malik; J D Ward
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

8.  Concurrent sickle cell hemoglobin C disease and diabetes mellitus: no added risk of proliferative retinopathy?

Authors:  P R Koduri; A R Patel; H A Bernstein
Journal:  J Natl Med Assoc       Date:  1994-09       Impact factor: 1.798

9.  Correction by pentoxifylline of the abnormal fluorescence polarization of erythrocyte membranes from diabetic patients.

Authors:  D Rahmani-Jourdheuil; I Juhan-Vague; C Roul; Y Mourayre; Z Mishal; J le Petit; P Vague
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  No decreased erythrocyte deformability in type 1 (insulin-dependent) diabetes, either by filtration or by ektacytometry.

Authors:  N H Schut; E C van Arkel; M R Hardeman; H J Bilo; R P Michels; J Vreeken
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.